Tourmaline Bio

Tourmaline Bio

Developing transformative medicines that dramatically improve the lives of patients with life-altering immune diseases. Learn more

Launch date
Employees
Market cap
€449m
Enterprise valuation
€186m (Public information from Sep 2024)
New York City New York (HQ)
Authorizing premium user...